Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vaccinex Inc
(NQ:
VCNX
)
5.069
-0.061 (-1.19%)
Streaming Delayed Price
Updated: 12:41 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vaccinex Inc
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Friday's After-Market Session
March 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 17, 2023
Via
Benzinga
MarketBeat Week in Review – 2/6 - 2/10
February 11, 2023
Markets are closed the week looking for direction as investors believe a soft landing is not possible and higher interest rates are likely
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Economy
Interest Rates
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 08, 2023
Via
Benzinga
Why Is Vaccinex (VCNX) Stock Up 67% Today?
February 07, 2023
Vaccinex (VCNX) stock is rocketing higher on Tuesday despite a lack of news from the clinical-stage biotechnology company.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
February 08, 2023
Our coverage starts today with a look at the biggest pre-market stock movers traders will want to keep an eye on Wednesday!
Via
InvestorPlace
Why Sintx Technologies Shares Are Trading Lower By 38%; Here Are 20 Stocks Moving Premarket
February 08, 2023
Gainers PainReform Ltd. (NASDAQ: PRFX) shares rose 89.5% to $0.9475 in pre-market trading. PainReform reported receipt of extension to Aug. 7, 2023 to meet the Nasdaq's minimum bid price requirement.
Via
Benzinga
Should Investors Buy or Sell the Vaccinex Patent News?
February 07, 2023
Shares of Vaccinex, Inc. are higher on February 7 on news that the clinical-stage biotechnology company secured a patent. Is it time to buy or sell the news?
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Why Is Rubius Therapeutics (RUBY) Stock Down 16% Today?
February 07, 2023
Rubius Therapeutics (RUBY) stock is falling hard on Tuesday after the biotechnology company received a Nasdaq delisting notice.
Via
InvestorPlace
Why Is Bed Bath & Beyond (BBBY) Stock Down 32% Today?
February 07, 2023
Bed Bath & Beyond (BBBY) stock is falling on Tuesday after the retailer revealed plans to raise $1 billion and warned of investing risks.
Via
InvestorPlace
Why Is Oak Street Health (OSH) Stock Up 36% Today?
February 07, 2023
Oak Street Health (OSH) stock is on the rise Tuesday as investors react to a report that CVS (CVS) plans to take over the company.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 07, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
February 07, 2023
It's time to start the day with a breakdown of the biggest pre-market stock movers investors will want to watch on Tuesday!
Via
InvestorPlace
The 3 Best Biotech Stocks Under $1 to Buy for January
January 26, 2023
Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich.
Via
InvestorPlace
Vaccinex Announces First Patient Dosed with Anti-CCR8 Antibody Licensed to Surface Oncology
January 09, 2023
Surface Oncology initiates clinical trial with antibody discovered using Vaccinex’s ActivMAb® Antibody Discovery Platform
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex Announces $3.8 Million Private Placement
November 28, 2022
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex Reports Third Quarter 2022 Results and Provides Corporate Update
November 14, 2022
Continued Progress in Pepinemab Oncology and Neurology Clinical Programs
From
Vaccinex, Inc.
Via
GlobeNewswire
Vaccinex and its Collaborators Present Two Abstracts Related to Pepinemab Combination Immunotherapy Trials at 37th Annual Meeting of Society for Immunotherapy of Cancer
November 10, 2022
New Biomarkers of Response and Resistance that Suggest Pepinemab Could Offer New Combination Treatment Options
From
Vaccinex, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 27, 2022
Gainers Clearside Biomedical (NASDAQ:CLSD) stock rose 27.3% to $1.35 during Thursday's pre-market session. The market value of their outstanding shares is at $81.2 million.
Via
Benzinga
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
October 26, 2022
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 02, 2022
Via
Benzinga
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
September 26, 2022
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.
Via
Benzinga
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
September 23, 2022
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day...
Via
Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
April 10, 2022
Biotech stocks managed to carve out modest gains for the week ending April 8, defying the broader market weakness. The defensive nature of the stocks make them appealing in times of risk aversion.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
September 21, 2022
On Wednesday, 340 stocks hit new 52-week lows.
Via
Benzinga
23 Stocks Moving in Thursday's Pre-Market Session
March 31, 2022
Gainers IZEA Worldwide, Inc. (NASDAQ: IZEA) rose 33.3% to $1.92 in pre-market trading after the company reported Q4 EPS results up from last year and better-than-expected sales...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 20, 2022
On Tuesday, 507 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
September 07, 2022
On Wednesday, 297 companies achieved new lows for the year.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 01, 2022
On Thursday, 529 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
August 31, 2022
On Wednesday, 238 companies achieved new lows for the year.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.